125 related articles for article (PubMed ID: 38150941)
1. Current understanding of comparative pathology and prospective research approaches for canine hemangiosarcoma.
Suzuki T; Henshaw MJ; Yanagi T; Aoshima K
Res Vet Sci; 2024 Feb; 167():105120. PubMed ID: 38150941
[TBL] [Abstract][Full Text] [Related]
2. Anticancer effects of resveratrol in canine hemangiosarcoma cell lines.
Carlson A; Alderete KS; Grant MKO; Seelig DM; Sharkey LC; Zordoky BNM
Vet Comp Oncol; 2018 Jun; 16(2):253-261. PubMed ID: 29235249
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and adverse events of anthracycline and propranolol combination in five dogs with stage 3 hemangiosarcoma.
Terauchi M; Fujii Y; Goto S; Iwasaki R; Yoshikawa R; Mori T
Open Vet J; 2023 Jun; 13(6):801-806. PubMed ID: 37545711
[TBL] [Abstract][Full Text] [Related]
4. Chromatin run-on sequencing analysis finds that ECM remodeling plays an important role in canine hemangiosarcoma pathogenesis.
Mukai C; Choi E; Sams KL; Klampen EZ; Anguish L; Marks BA; Rice EJ; Wang Z; Choate LA; Chou SP; Kato Y; Miller AD; Danko CG; Coonrod SA
BMC Vet Res; 2020 Jun; 16(1):206. PubMed ID: 32571313
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.
U'Ren LW; Biller BJ; Elmslie RE; Thamm DH; Dow SW
J Vet Intern Med; 2007; 21(1):113-20. PubMed ID: 17338158
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome in 20 cases of lingual hemangiosarcoma in dogs: 1996-2011.
Burton JH; Powers BE; Biller BJ
Vet Comp Oncol; 2014 Sep; 12(3):198-204. PubMed ID: 22905712
[TBL] [Abstract][Full Text] [Related]
7. Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma.
Estabrooks T; Gurinovich A; Pietruska J; Lewis B; Harvey G; Post G; Lambert L; Miller A; Rodrigues L; White ME; Lopes C; London CA; Megquier K
Vet Comp Oncol; 2023 Dec; 21(4):623-633. PubMed ID: 37734854
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of endothelin inhibitors in canine hemangiosarcoma.
Fukumoto S; Saida K; Sakai H; Ueno H; Iwano H; Uchide T
Life Sci; 2016 Aug; 159():55-60. PubMed ID: 26835989
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an autologous cancer vaccine for the treatment of metastatic canine hemangiosarcoma: a preliminary study.
Lucroy MD; Clauson RM; Suckow MA; El-Tayyeb F; Kalinauskas A
BMC Vet Res; 2020 Nov; 16(1):447. PubMed ID: 33208160
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the oncogenomic landscape of canine and feline hemangiosarcoma shows novel parallels with human angiosarcoma.
Wong K; Ludwig L; Krijgsman O; Adams DJ; Wood GA; van der Weyden L
Dis Model Mech; 2021 Jul; 14(7):. PubMed ID: 34296746
[TBL] [Abstract][Full Text] [Related]
11. Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma.
Wang G; Wu M; Durham AC; Radaelli E; Mason NJ; Xu X; Roth DB
PLoS One; 2020; 15(3):e0229728. PubMed ID: 32210430
[TBL] [Abstract][Full Text] [Related]
12. Manipulating histone acetylation leads to antitumor effects in hemangiosarcoma cells.
Suzuki T; Aoshima K; Yamazaki J; Kobayashi A; Kimura T
Vet Comp Oncol; 2022 Dec; 20(4):805-816. PubMed ID: 35568976
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and prognosis of retroperitoneal hemangiosarcoma in dogs with surgical resection with or without adjuvant doxorubicin.
Ichimata M; Toshima A; Matsuyama F; Fukazawa E; Harada K; Katayama R; Kagawa Y; Yamagami T; Kobayashi T
J Vet Med Sci; 2023 Nov; 85(11):1231-1236. PubMed ID: 37853623
[TBL] [Abstract][Full Text] [Related]
14. Treatment of canine hemangiosarcoma: 2000 and beyond.
Clifford CA; Mackin AJ; Henry CJ
J Vet Intern Med; 2000; 14(5):479-85. PubMed ID: 11012108
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma.
Andersen NJ; Nickoloff BJ; Dykema KJ; Boguslawski EA; Krivochenitser RI; Froman RE; Dawes MJ; Baker LH; Thomas DG; Kamstock DA; Kitchell BE; Furge KA; Duesbery NS
Mol Cancer Ther; 2013 Sep; 12(9):1701-14. PubMed ID: 23804705
[TBL] [Abstract][Full Text] [Related]
16. In vitro effects of PI3K/mTOR inhibition in canine hemangiosarcoma.
Pyuen AA; Meuten T; Rose BJ; Thamm DH
PLoS One; 2018; 13(7):e0200634. PubMed ID: 30011343
[TBL] [Abstract][Full Text] [Related]
17. Primary appendicular hemangiosarcoma and telangiectatic osteosarcoma in 70 dogs: A Veterinary Society of Surgical Oncology retrospective study.
Giuffrida MA; Kamstock DA; Selmic LE; Pass W; Szivek A; Mison MB; Boston SE; Fox LE; Robat C; Grimes JA; Maritato KC; Bacon NJ
Vet Surg; 2018 Aug; 47(6):774-783. PubMed ID: 30051473
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of conjunctival hemangioma and hemangiosarcoma: A retrospective study of 52 dogs.
Richardson S; Deykin AR
Vet Ophthalmol; 2021 Sep; 24(5):432-441. PubMed ID: 34402571
[TBL] [Abstract][Full Text] [Related]
19. Hemangiosarcoma in dogs and cats.
Smith AN
Vet Clin North Am Small Anim Pract; 2003 May; 33(3):533-52, vi. PubMed ID: 12852235
[TBL] [Abstract][Full Text] [Related]
20. Molecular prevalence of Bartonella, Babesia, and hemotropic Mycoplasma species in dogs with hemangiosarcoma from across the United States.
Lashnits E; Neupane P; Bradley JM; Richardson T; Thomas R; Linder KE; Breen M; Maggi RG; Breitschwerdt EB
PLoS One; 2020; 15(1):e0227234. PubMed ID: 31923195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
